ArticleTherapeutic advances in urology

Prognostic factors and treatment choice for stage IV, low-volume metastasis hormone-sensitive prostate cancer: cross-sectional study of real-world data.

Mohamed Ibrahim Elewaily et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.